Welcome to our dedicated page for Addus HomeCare SEC filings (Ticker: ADUS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Addus HomeCare Corporation filings document a home care provider with personal care, hospice and home health operations. Form 8-K reports furnish quarterly and annual results of operations, Regulation FD disclosures and exhibit press releases, while amended 8-K filings provide acquisition-related financial statements and pro forma information for the completed purchase of Gentiva's personal care business by Addus HealthCare, a wholly owned subsidiary.
Proxy and annual-meeting filings cover board elections, auditor ratification, executive compensation votes and related governance disclosures. The filing record also includes capital-structure, material-event and shareholder-vote disclosures for the company's common stock.
Addus HomeCare Corp Executive Vice President and Chief Financial Officer Brian Poff reported two stock transactions. On February 20, 2026, he acquired 11,431 shares of common stock as a grant that will vest in three equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions.
On February 23, 2026, he sold 1,858 shares of common stock at $114.91 per share in an open-market transaction pursuant to a previously established Rule 10b5-1 trading plan, to cover tax obligations from restricted stock vesting. After the sale, he directly owned 66,553 shares of Addus common stock.
Addus HomeCare Corp reported that President and Chief Operating Officer Heather Brianne Dixon acquired a grant of 12,470 shares of common stock at no cost as equity compensation. These shares vest in equal installments on February 20 of 2027, 2028, and 2029, subject to continued service and change-in-control provisions. Following this grant, she directly holds a total of 44,659 common shares.
Addus HomeCare Corp Chairman and CEO Allison R. Dirk reported both a stock grant and a tax-related share sale. He received a grant of 28,576 shares of common stock that vest in equal parts on February 20 of 2027, 2028, and 2029. He also sold 4,535 shares at $114.91 per share under a previously established Rule 10b5-1 plan to cover tax obligations from restricted stock vesting, and held 190,502 shares afterward.
Addus HomeCare Corporation reported strong growth for the fourth quarter and full year 2025. Fourth quarter net service revenues were $373.1 million, up 25.6% from $297.1 million a year earlier, with net income rising to $29.8 million or $1.61 per diluted share from $19.5 million or $1.07.
Adjusted EBITDA for the quarter increased 33.3% to $50.3 million. For full year 2025, net service revenues grew 23.2% to $1.42 billion, net income reached $95.9 million or $5.22 per diluted share, and adjusted EBITDA was $180.0 million, up from $140.3 million in 2024.
Personal care generated 76.6% of fourth quarter revenue, hospice 18.8%, and home health 4.6%. The company highlighted organic growth in personal care and hospice, state rate increases in Texas and Illinois, year-end cash of $81.6 million, and reduced bank debt of $124.3 million.
Capital Research Global Investors filed an amended Schedule 13G reporting a passive ownership stake in Addus HomeCare Corp. common stock. The firm is deemed to beneficially own 1,469,752 shares, representing 8.0% of the issuer’s 18,483,271 shares believed outstanding as of December 31, 2025.
The shares are held in the ordinary course of business and not with the purpose or effect of changing or influencing control of Addus HomeCare. The filing notes that SMALLCAP World Fund, Inc. has the right to receive dividends or sale proceeds for more than 5% of the class.
Wasatch Advisors filed an amended Schedule 13G reporting its beneficial ownership in Addus HomeCare Corp. The firm reports beneficial ownership of 907,501 shares, representing 4.9% of the common stock class.
Wasatch Advisors has sole voting power over 619,613 shares and sole dispositive power over all 907,501 shares. The filing states the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Addus HomeCare Corp.
Addus HomeCare Corp director Esteban Lopez reported selling a total of 150 shares of the company’s common stock on 12/15/2025. The Form 4 discloses two separate sales: 50 shares at a price of $114.55 and 100 shares at $115.50, each recorded as a disposition of common stock. After these transactions, Lopez beneficially owns 3,700 shares of Addus HomeCare common stock in direct ownership.
Addus HomeCare Corp executive Darby Anderson, EVP and Chief Government Relations Officer, reported an option exercise and share sale. On 11/19/2025, Anderson exercised 20,000 employee stock options at an exercise price of $22.70 per share, acquiring the same number of Addus HomeCare common shares. On the same date, Anderson sold 20,000 common shares at a price of $109 per share.
After these transactions, Anderson directly beneficially owned 44,144 shares of Addus HomeCare common stock, and held 0 remaining employee stock options. The filing notes that all options involved in this transaction were fully vested.
Addus HomeCare (ADUS) reported solid Q3 2025 growth, with net service revenues of $362.3 million, up from $289.8 million a year ago. Operating income rose to $32.9 million from $26.0 million, and net income increased to $22.8 million from $20.2 million. Diluted EPS was $1.24 versus $1.10.
Growth was broad-based: personal care delivered $275.8 million, hospice $68.9 million, and home health $17.6 million. For the first nine months, revenue reached $1.05 billion (from $857.5 million), with net income of $66.1 million (from $54.1 million) and diluted EPS of $3.60 (from $3.17). Cash from operations was $92.7 million.
Addus completed the Helping Hands acquisition on August 1 for approximately $21.4 million, adding $3.1 million of quarterly revenue and $0.4 million of operating income. The company continued to streamline its portfolio, progressing on the New York asset sale and recording $3.8 million in deferred payments year-to-date, with $2.3 million remaining as of September 30, 2025. Long-term revolver borrowings declined to $154.3 million from $223.0 million, and the company remained in compliance with credit covenants. Shares outstanding were 18,483,271 as of October 28, 2025.
Addus HomeCare Corporation furnished a Form 8-K announcing its results of operations for the fiscal quarter ended September 30, 2025. The company disclosed this through a press release attached as Exhibit 99.1, which is incorporated by reference.
The filing confirms the announcement date of November 3, 2025 and lists the company’s common stock trading as ADUS on The Nasdaq Stock Market. Detailed financial and operational results are presented in the attached press release.